Yttrium (90Y) tacatuzumab tetraxetan is a radiopharmaceutical used in targeted radiotherapy, particularly for the treatment of certain types of cancers. In this compound: - **Yttrium-90 (90Y)**: This is a radioactive isotope of yttrium that emits beta particles, which can destroy cancer cells. Its radioactive properties make it effective for therapeutic purposes.

Articles by others on the same topic (0)

There are currently no matching articles.